PROVIDER PROFILE · NPI 1396775979

Robyn YoungM.D.

PRACTICEBARBARA ANN MCQUINN, M.D., A PROFESSIONAL CORP.See all providers at this practice →

NeurologyAlameda, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

264

Unique beneficiaries

—

Total services

817

Distinct HCPCS

Medicare payment

$83K

Peer benchmark

Total Medicare services vs. 1,670 Neurology providers in CA — above median (cohort median 581).

PRESCRIBING · PART D · 2024

Total Rx claims

2,199

Beneficiaries

—

Total drug cost

$1.2M

Distinct drugs

Brand share

33.0%

Top prescribed drugs

Gabapentin182 claims

Lorazepam109 claims

Duloxetine Hcl108 claims

Hydrocodone/Acetaminophen106 claims

Morphine Sulfate95 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

REFERRAL NETWORK

Where Robyn Young's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 7 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
SUTTER EAST BAY HOSPITALS	16	61

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · Sacramento, CA	34	84
ALAMEDA HEALTH SYSTEM	27	177
SUTTER EAST BAY HOSPITALS	23	88
C. Michael Neuwelt Rheumatology · San Leandro, CA	19	55
SUTTER EAST BAY HOSPITALS	18	55
MEDICAL CENTER MAGNETIC IMAGING, LLC	14	24
Laboratory Corporation Of America Clinical Laboratory · San Diego, CA	12	25

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history